Create issue ticket

980 Possible Causes for Proteins,, Rapamycin Binding

Did you mean: Proteins, Rapamycin, Binding

  • Protein Losing Enteropathy

    Differential diagnoses for low protein levels are reduced intake or malnutrition, decreased protein synthesis due to hepatic dysfunctions, and protein losing nephropathy.[] At the time of writing this report, the beneficial effect of sirolimus has lasted for more than 3 years.[] She also had severe protein C and protein S depletion from GI loss which caused extensive thrombosis.[]

  • Lipoma

    S100 protein reactivity has rarely been observed in classical and plexiform spindle cell lipoma.[] In addition, the phosphorylation of protein kinase B and downstream targets of mammalian target of rapamycin and 4E‑binding protein (4E‑BP)‑1 was attenuated.[] Treatment of the lipoma with an injection of XIAFLEX (a protein that breaks down collagen fibers) may dissolve the collagen/fibrous strands thereby decreasing the size of[]

  • Gastric Cancer

    Proline-rich protein 11 (PRR11) has been shown to be up-regulated in human cancers; however, its role in gastric CSCs is unknown.[] In addition, corosolic acid activated AMPK, and decreased TS expression and the phosphorylation of mammalian target of rapamycin/4E‑binding protein 1 in a dose‑dependent manner[] , human FGFR2 protein, human Receptor, ErbB-2 Receptor, Fibroblast Growth Factor, Type 2 DDX6 protein, human DEAD-box RNA Helicases[]

  • Cerivastatin

    OBJECTIVE: C-reactive protein (CRP) concentrations, butyrylcholinesterase (BChE) activity, total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein[] Sirolimus and CsA trough levels, and the sirolimus AUC did not differ after single dose and multiple doses of cerivastatin.[] Withdrawal increased the activity of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase and enhanced radical generation.[]

  • Phentolamine

    This study reports the cerebral effects of phentolamine using blood S100B protein levels and the middle cerebral artery pulsatility index (MCA PI).[] A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. ‎[] Such procedure causes a reduction in fluorescence intensity of the aromatic tryptophan (Trp) residues, and the R-T transition of the globular protein occurred concurrently[]

  • Probucol

    Abstract Probucol, an antioxidative and hypolipidemic agent, has been postulated to increase reverse cholesterol transport by enhancing cholesteryl ester transfer protein[] The trial was designed to demonstrate noninferiority of the sirolimus- and probucol-eluting stents.[] The present study examined whether the decreased level of ADMA by probucol is related to enhancement of protein arginine methyltransferase I (PRMT I) expression and reduction[]

  • Shock

    The prepared nanocomposites were also used to screen proteins from a mixture of cellular extracts, and five proteins from HeLa cells were identified as potential client proteins[] Her coronary angiographic finding demonstrated a dissection in the mid-distal segment of the left main coronary artery where a sirolimus-eluting stent was deployed.[] In the current study, we show Heat shock protein 90 is essential for its growth.[]

  • Pleural Effusion

    , human ERBB3 protein, human Receptor, ErbB-2 Receptor, ErbB-3[] Following the withdrawal of sirolimus therapy her symptoms resolved within three months.[] […] pleural fluid protein electrophoresis.[]

  • Hepatitis

    For example, it produces albumin, the protein building block of the body, as well as the proteins that cause blood to clot properly.[] […] after sirolimus withdrawal were findings strongly suggestive of sirolimus-induced hepatitis.[] BMP6 and related activin proteins potently block replication of HCV, hepatitis B virus and Zika virus independently of IFN. Lucy A.[]

  • Topotecan

    Oligonucleotides, Antisense Proto-Oncogene Proteins c-bcl-2 Vinblastine Topotecan[] Sirolimus steady-state plasma trough concentrations of 3-7.9 ng/mL and 8-12.0 ng/mL were evaluated, with dose escalation based on a 3 3 phase 1 design.[] Spectrofluorimetric data confirmed the static nature of the quenching mechanism of the protein induced by the drug.[]

Further symptoms